Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
The role of the pharmacist in supporting multi-disciplinary education
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
The role of the pharmacist in supporting multi-disciplinary education ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
Effective communication about biosimilars
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
Effective communication about biosimilars ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
Assessing biosimilars in the real world setting
Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands
Assessing biosimilars in the real world setting ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )
8 Oct 2019
Realising the potential of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Realising the potential of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Supporting a sustainable biosimilar solution
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Supporting a sustainable biosimilar solution ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Use of biosimilar monoclonal antibodies in the clinic
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Use of biosimilar monoclonal antibodies in the clinic ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Critical quality attributes of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Critical quality attributes of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Immunogenicity of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Immunogenicity of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Quality of life results from pembrolizumab vs chemotherapy in gastric or gastroe...
Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain
Quality of life results from pembrolizumab vs chemotherapy in gastric or gastroesophageal junction cancer ( Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain )
8 Oct 2019
ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma
Jonathan Ledermann - University College Hospital, London, UK
ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma ( Jonathan Ledermann - University College Hospital, London, UK )
7 Oct 2019
PARP inhibitors for metastatic breast cancer
Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany
PARP inhibitors for metastatic breast cancer ( Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany )
7 Oct 2019
KATHERINE trial updates for HER2-positive breast cancer
Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany
KATHERINE trial updates for HER2-positive breast cancer ( Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany )
7 Oct 2019